{"id":106372,"name":"ELI LILLY & CO INC","slug":"eli-lilly-co-inc","state":"IN","country":"United States of America","description":"","totalSpending":350000,"filings":9,"yearlySpending":[{"year":2018,"income":200000},{"year":2019,"income":150000},{"year":2020,"income":0}],"issues":[{"code":"HCR","display":"Health Issues"}],"firms":["BGR GOVERNMENT AFFAIRS"],"lobbyists":["ROBERT WOOD","DAVID BOYER","BRENT DEL MONTE","ROBB WALTON","JOHN STONE","MATT HOFFMANN","REMY MASON"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","Food & Drug Administration (FDA)"],"sampleDescriptions":["Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics; implementation of health care reform; PDUFA; FDA reform; Trade issues","Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics; implementation of health care reform; PDUFA; FDA reform; Trade issues","Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics; implementation of health care reform; PDUFA; FDA reform; Trade issues","Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics; implementation of health care reform; PDUFA; FDA reform; Trade issues","Patent reform; Medicare Part-D non-interference legislation; Medicaid rebates; Follow-on biologics; implementation of health care reform; PDUFA; FDA reform; Trade issues"]}